from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1072/-

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

0.295

Cap5-10ug/mL Capreomycintranslation

-1.504

Rox10-50 ug/mL Roxithromycintranslation

0.132

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.529

Rif0.2-5ug/mL Rifampicintranscription

-0.932

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.259

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.790

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.060

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.522

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.471

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.551

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.684

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.100

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.347

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.143

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.272

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.436

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.595

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.071

KCN5-20 ug/mL Potassium cyaniderespiration

-0.714

NaN30.2-2 mM Sodium aziderespiration

-0.271

Nigericin50 uM Nigericinrespiration

-0.295

TRC10-150 ug/mL Triclosanrespiration

1.355

TRZ10-25 ug/mL Thioridazinerespiration

-0.036

Valinomycin0.5-10 uM Valinomycinrespiration

-1.228

ZnSO42 mM ZnSO4respiration

1.120

menadione6-10 ug/mL Menadionerespiration

0.403

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.441

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.578

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.262

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.030

NRP_1Non-replicating persistence stage 1dosRassociated

1.135

Amp0.2mg/mL AmpicillincellWall

-0.566

Cephalexin20-100 ug/mL CephalexincellWall

0.363

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.389

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.278

EMB10-20 ug/mL EthambutolcellWall

0.000

Eta12-40 ug/mL EthionamidecellWall

-0.940

INH0.2-0.4 ug/mL IsoniazidcellWall

0.473

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-2.187

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-2.223

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.986

BZA0.12 mg/mL BenzamidearomaticAmides

0.687

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.118

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.133

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

0.013

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.340

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.117

UVUV-irradiationDNAdamaging

-0.037

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.249

Antimycin12.5-50 ug/mL Antimycin A?

-1.118

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.142

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.098

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.006

PA8240.2-2 ug/mL PA-824?

0.804

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.600

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.319

Verapamil50 uM Verapamil?

-1.026

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.558

methoxatin10-20 ug/mL Methoxatin?